An Influence of Endometrial Hyperplasia Regarding Pathos Physiology, Diagnosis, Differential Diagnosis, Treatment, Complications and Consultations

An Influence of Endometrial Hyperplasia Regarding Pathos Physiology, Diagnosis, Differential Diagnosis, Treatment, Complications and Consultations Description Endometrial hyperplasia is a uterine pathology in which morphological changes happen in the cells of the endometrium and exemplifies a precursor to the most common gynecologic malignancy in developed countries, endometrial cancer. It is most commonly caused by increased estrogen exposure and a relative lack of progesterone, which is known as "unopposed estrogen." Because risk factors are increasing at the same time as obesity, diabetes, or other linked conditions, the condition's incidence is increasing. In order to successfully stop the development of endometrial cancer, doctors need to be aware of the symptoms of endometrial hyperplasia, especially if they are treating patients who also have obesity and polycystic ovarian disease. Healthcare practitioners will graduate from this course with a thorough understanding of the etiology, diagnosis, and treatment of endometrial hyperplasia. In addition to examining the most recent developments in diagnostic methods, therapeutic approaches, and preventative measures, the importance of an interprofessional care team in early diagnosis and referral for suitable intervention is emphasized. This exercise highlights the value of assisting patients in making decisions about their fertility objectives and surgical risk factors, as well as facilitating early intervention. By gaining the knowledge and abilities required to properly diagnose, assess, and treat patients with endometrial hyperplasia, participants can ultimately slow the spread of endometrial cancer and improve patient outcomes and care quality. Files An Influence of Endometrial Hyperplasia Regarding Pathos Physiology -Formatted Paper.pdf Files (435.3 kB) | Name | Size | Download all | |---|---|---| | md5:30cd6cd6d4706265e7b12e33b4241d51 | 435.3 kB | Preview Download | Additional details References - 1. Contreras, N. A., Sabadell, J., Verdaguer, P., Julià, C., & Fernández-Montolí, M. E. (2022). Fertility-sparing approaches in atypical endometrial hyperplasia and endometrial cancer patients: Current evidence and future directions. International Journal of Molecular Sciences, 23(5), Article 2856. https://doi.org/10.3390/ijms23052856 - 2. Nees, L. K., Heublein, S., Steinmacher, S., Juhasz-Böss, I., Brucker, S., Tempfer, C. B., & Wallwiener, M. (2022). Endometrial hyperplasia as a risk factor for endometrial cancer. Archives of Gynecology and Obstetrics, 306(2), 407-421. https://doi.org/10.1007/s00404-022-06711-7 - 3. Sanderson, P. A., Critchley, H. O., Williams, A. R., Arends, M. J., & Saunders, P. T. (2017). New concepts for an old problem: The diagnosis of endometrial hyperplasia. Human Reproduction Update, 23(2), 232-254. https://doi.org/10.1093/humupd/dmw051 - 4. Shen, Y., Yang, W., Liu, J., & Zhang, Y. (2023). Minimally invasive approaches for the early detection of endometrial cancer. Molecular Cancer, 22(1), Article 53. https://doi.org/10.1186/s12943-023-01843-w - 5. Lathigara, D., Kaushal, D., & Wilson, R. B. (2023). Molecular mechanisms of western diet-induced obesity and obesity-related carcinogenesis: A narrative review. Metabolites, 13(5), Article 686. https://doi.org/10.3390/metabo13050686 - 6. Chittenden, B. G., Fullerton, G., Maheshwari, A., & Bhattacharya, S. (2009). Polycystic ovary syndrome and the risk of gynecological cancer: A systematic review. Reproductive BioMedicine Online, 19(3), 398-405. https://doi.org/10.1016/j.rbmo.2009.05.010 - 7. Schumer, S. T., & Cannistra, S. A. (2003). Granulosa cell tumor of the ovary. Journal of Clinical Oncology, 21(6), 1180-1189. https://doi.org/10.1200/JCO.2003.04.076 - 8. Lee, M., Piao, J., & Jeon, M. J. (2020). Risk factors associated with endometrial pathology in premenopausal breast cancer patients treated with tamoxifen. Yonsei Medical Journal, 61(4), 317-322. https://doi.org/10.3349/ymj.2020.61.4.317 - 9. Lancaster, J. M., Powell, C. B., Chen, L. M., Richardson, D. L., & Society of Gynecologic Oncology Clinical Practice Committee. (2015). Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions. Gynecologic Oncology, 136(1), 3-7. https://doi.org/10.1016/j.ygyno.2014.10.034 - 10. Ryan, N. A. J., McMahon, R., Tobi, S., Snowsill, T., Esquibel, S., Wallace, A. J., Bunstone, S., Bowers, N., Mosneag, I. E., Kitson, S. J., O'Flynn, H., Ramchander, N. C., Sivalingam, V. N., Frayling, I. M., Bolton, J., McVey, R. J., Evans, D. G., & Crosbie, E. J. (2020). The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study. PLOS Medicine, 17(9), Article e1003263. https://doi.org/10.1371/journal.pmed.1003263